Form D
View Original Filing
Notice of Exempt Offering of Securities
Item 1. Issuer's Identity
Name of Issuer:
REPLIGEN CORP
Jurisdiction of Incorporation/Organization
DELAWARE
Year of Incorporation/Organization
Over Five Years Ago
Item 2 Issuer Principal Place of Business and Contact Information
41 SEYON STREET
BUILDING 1, SUITE 100
WALTHAM, MA 02453
Phone Number:
subscription required
Item 3. Related Persons
Name
TONY J. HUNT
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
JON K. SNODGRES
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
RALF J. KURIYEL
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
THOMAS F. RYAN, JR.
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
GLENN P. MUIR
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
JOHN G. COX
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
GLENN L. COOPER
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
NICOLAS M. BARTHELEMY
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
KAREN A. DAWES
Address
subscription required
Relationship(s)
Clarification of Response
Item 4. Industry Group
OTHER HEALTH CARE
Item 5. Issuer Size
Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE
Item 6. Federal Exemptions and Exclusions Claimed
Item 7. Type of Filing
New Notice
Date of First Sale in this Offering:
05/31/2019
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
No
Item 9. Type(s) of Securities Offered
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
Yes
Clarification of Response
PRIVATE SALE PART OF CONSIDERATION FOR REPLIGEN CORPORATION'S ACQUISITION OF C TECHNOLOGIES, INC.
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
0
Item 13. Offering and Sales Amounts
Total Offering Amount
48000000
Total Amount Sold
48000000
Total Remaining to be Sold
0
Clarification of Response
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
1
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
0.0
Finders' Fees
0.0
Clarification of Response
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response
Signature and Submission
Issuer Name
REPLIGEN CORP
Issuer Signature
TONY J. HUNT
Signer Name
TONY J. HUNT
Signer Title
CHIEF EXECUTIVE OFFICER
Signature Date
06/13/2019